Page last updated: 2024-08-25

propagermanium and Metabolic Syndrome

propagermanium has been researched along with Metabolic Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akamizu, T; Arai, H; Ariyasu, H; Kanamori, H; Kita, T; Murayama, T; Ono, K; Sugimoto, M; Tamura, Y; Ueda, Y; Yokode, M	1

Other Studies

1 other study(ies) available for propagermanium and Metabolic Syndrome

Article	Year
Inhibition of CCR2 ameliorates insulin resistance and hepatic steatosis in db/db mice. Arteriosclerosis, thrombosis, and vascular biology, 2008, Volume: 28, Issue:12 Topics: Adipose Tissue; Adiposity; Animals; Cell Size; Fatty Liver; Germanium; Insulin Resistance; Liver; Macrophages; Male; Metabolic Syndrome; Mice; Mice, Mutant Strains; Mice, Obese; Obesity; Organometallic Compounds; Propionates; Receptors, CCR2; Triglycerides; Weight Gain	2008

Article

Year

Inhibition of CCR2 ameliorates insulin resistance and hepatic steatosis in db/db mice.

Arteriosclerosis, thrombosis, and vascular biology, 2008, Volume: 28, Issue:12

Topics: Adipose Tissue; Adiposity; Animals; Cell Size; Fatty Liver; Germanium; Insulin Resistance; Liver; Macrophages; Male; Metabolic Syndrome; Mice; Mice, Mutant Strains; Mice, Obese; Obesity; Organometallic Compounds; Propionates; Receptors, CCR2; Triglycerides; Weight Gain

2008